Fulcrum Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-04-27 10:35:38 ET FULC

Published on 04/27/2026 at 10:35 am EDT

Fulcrum Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported net loss was USD 18.89 million compared to USD 17.66 million a year ago. Basic loss per share from continuing operations was USD 0.25 compared to USD 0.28 a year ago.

Diluted loss per share from continuing operations was USD 0.25 compared to USD 0.28 a year ago.